Exits

Namesort icon Description Event Date Acquired By
<a href="http://www.idexx.com" target="_blank">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care IPO 1991
<a href="http://www.insmed.com" target="_blank">INSMED, Incorporated</a> Pharmaceuticals for treatment of metabolic diseases and endocrine disorders IPO 2000
<a href="http://www.adt.com/medium_large_business/products_services/video_surveillance" target="_blank">IntelliVid</a> Machine intelligence for video security Acquired 2008 Tyco International
<a href="http://www.microsoft.com" target="_blank">Interactive Supercomputing Corporation</a> Software to enable applications transparent use of cluster supercomputers Acquired 2009 <a href="http://www.microsoft.com" target="_blank">Microsoft Corporation</a>
<a href="http://www.morphotek.com" target="_blank">Morphotek, Inc.</a> Genetically diverse organisms for agricultural, life science, and pharmaceutical use Acquired 2007 <a href="http://www.eisai.com" target="_blank">Eisai Company</a>
<a href="http://www.curis.com" target="_blank">Ontogeny, Inc.</a> Developmental biology insights for regenerative medicine therapies Acquired 2000 <a href="http://www.curis.com" target="_blank">Curis, Inc.</a>
<a href="http://www.appliedbiosystems.com" target="_blank">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1998 <a href="http://www.appliedbiosystems.com" target="_blank">Applied Biosystems</a>
Pervasis Therapeutics, Inc. Developing novel therapeutics to promote vascular repair. Acquired 2012 <a href="/www.shire.com" target="_blank">Shire</a>
Receptos, Inc. Developing therapeutic candidates for the treatment of immune and metabolic diseases. IPO 2013
<a href="/www.evotec.com" target="_blank">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders IPO 2004
Resolvyx Pharmaceuticals, Inc. Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Acquired 2011 <a href="http://www.celtictherapeutics.com/" target="_blank">Celtic Therapeutics</a>
Somatogen Synthetic hemoglobin products for use in blood transfusion Acquired 1998 <a href="http://www.baxter.com" target="_blank">Baxter International</a>
Tetraphase Pharmaceuticals, Inc. Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. IPO 2013
<a href="http://www.tripadvisor.com" target="_blank">TripAdvisor LLC</a> Leading global travel information and advice destination on the web Acquired 2004 <a href="http://www.expediainc.com/" target="_blank">Expedia, Inc.</a>
VisEn Medical, Inc. Pioneering a new era of in vivo imaging. Acquired 2010 <a href="http://www.perkinelmer.com" target="_blank">PerkinElmer</a>
<a href="http://www.combinatorx.com" target="_blank">Zalicus</a> Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. IPO 2005